- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07602595
The BRIDGE Pain Study (BRIDGE)
Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain
The purpose of the study is to discover at least two distinct Musculoskeletal pain subtypes. These types are caused by different brain-and-immune system signals that affect how the body feels pain, and they are also shaped by a person's biology, psychology, and social environment.
Aim 1. We want to sort adolescents and young adults with long lasting muscle and bone pain into two different groups. To do this, we will look at participants' childhood medical histories, past treatments, when their pain started, the sex they were assigned at birth, what their pain feels like now, tests of how their body senses pain, and immune system markers found in their blood. We think we will find at least two different types of chronic pain groups, plus one group of patients who had a higher risk for pain (because of a rheumatic disease or past surgery) but never developed long term pain.
Aim 2. We want to find out if certain patterns of inflammation in the body change how nerve cells react to pain.
Aim 3: We want to understand how different biological, psychological, and social factors are connected to the chronic pain groups we identified. We think we will find certain mental, behavioral, and social risks-as well as protective factors-that help explain why some people develop long-lasting pain and others do not. We expect these factors to play different roles in each pain group, including the group that does not develop chronic pain.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Megan Kirschman
- Telefoonnummer: 5136361846
- E-mail: bridgestudy@cchmc.org
Studie Locaties
-
-
Ohio
-
Cincinnati, Ohio, Verenigde Staten, 45211
- Werving
- Cincinnati Children's Hospital
-
Contact:
- Megan Kirschman
- Telefoonnummer: 5136361846
- E-mail: bridgestudy@cchmc.org
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Diagnosis of rheumatic/autoimmune disease/pain condition or surgery prior to age 18; Current age 14 to 26 years; Participant (and parent/legal guardian of participants < 18 yo) can read and write in English; At least 1 year from diagnosis of pain or rheumatic disease; For individuals with MSK surgical history, at least 1 year after initial surgical intervention; For individuals with rheumatic disease, their disease must be considered inactive
Exclusion Criteria:
- They have active disease, or Other major medical comorbidities have developed after surgery following MSK surgical intervention.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Primary musculoskeletal pain disorders
localized or widespread MSK pain
|
This is an observational study.
No intervention is present.
|
|
Inflammatory/autoimmune rheumatic diseases
juvenile idiopathic arthritis (JIA) and childhood-onset systemic lupus erythematosus (cSLE)
|
This is an observational study.
No intervention is present.
|
|
Major MSK surgeries
scoliosis and pectus excavatum repair
|
This is an observational study.
No intervention is present.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Conditioned Pain Modulation (CPM) Profile (Pressure)
Tijdsspanne: Baseline
|
CPM is defined by the change in pressure thresholds (increase) before and during cold immersion.
Pressure thresholds will be measured using an algometer.
|
Baseline
|
|
Conditioned Pain Modulation (CPM) Profile (Heat)
Tijdsspanne: Baseline
|
CPM is defined by the change in heat pain intensity (decrease) before and during cold immersion.
Heat stimuli will be delivered by a thermode and pain intensity measured by participant self report on the visual analog scale.
|
Baseline
|
|
Temporal Summation (TS) Profile
Tijdsspanne: Baseline
|
TS is defined by the change in mechanical pain intensity (increase) after exposure to a series of pinprick stimuli.
Pain intensity will be measured by participant self report on the visual analog scale.
|
Baseline
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Pijn
- Neurologische manifestaties
- Botziekten
- Musculoskeletale aandoeningen
- Ziekten van het zenuwstelsel
- Spierziekten
- Neuromusculaire aandoeningen
- Artritis
- Gewrichtsziekten
- Reumatische aandoeningen
- Bindweefselziekten
- Auto-immuunziekten
- Ziekten van het immuunsysteem
- Spinale ziekten
- Musculoskeletale afwijkingen
- Aangeboren afwijkingen
- Botziekten, ontwikkelingsstoornissen
- Spinale krommingen
- Aangeboren, erfelijke en neonatale ziekten en afwijkingen
- Pathologische aandoeningen, tekenen en symptomen
- Huid- en bindweefselaandoeningen
- Tekenen en symptomen
- Artritis, jeugd
- Musculoskeletale pijn
- Fibromyalgie
- Chronische pijn
- Scoliose
- Trechter kist
Andere studie-ID-nummers
- BRIDGE Pain
- 1UC2AR086503 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .